These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22863263)

  • 41. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation.
    Periera BJ; Wright TL; Schmid CH; Levey AS
    Transplantation; 1995 Oct; 60(8):799-805. PubMed ID: 7482738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand.
    Scott DR; Wong JK; Spicer TS; Dent H; Mensah FK; McDonald S; Levy MT
    Transplantation; 2010 Dec; 90(11):1165-71. PubMed ID: 20861806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis.
    Butt AA; Skanderson M; McGinnis KA; Ahuja T; Bryce CL; Barnato AE; Chang CC
    J Viral Hepat; 2007 Oct; 14(10):688-96. PubMed ID: 17875003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
    Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
    Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
    Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus infection and kidney disease: a meta-analysis.
    Fabrizi F; Martin P; Dixit V; Messa P
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):549-57. PubMed ID: 22403269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
    Kenfack-Momo R; Ngounoue MD; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Zeuko'o Menkem E; Lontuo Fogang R; Tchatchouang S; Ndzie Ondigui JL; Kame-Ngasse GI; Kenfack-Zanguim J; Magoudjou-Pekam JN; Bowo-Ngandji A; Mahamat M; Nkie Esemu S; Ndip L; Njouom R
    PLoS One; 2024; 19(2):e0284169. PubMed ID: 38330063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis.
    Wijarnpreecha K; Nissaisorakarn P; Sornprom S; Thongprayoon C; Thamcharoen N; Maneenil K; Podboy AJ; Cheungpasitporn W
    World J Gastrointest Pathophysiol; 2016 Nov; 7(4):314-319. PubMed ID: 27895977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature.
    Johnson JG; Gore SM; Firth J
    Nephrol Dial Transplant; 1999 Sep; 14(9):2156-64. PubMed ID: 10489225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?
    Jager KJ; Lindholm B; Goldsmith D; Fliser D; Wiecek A; Suleymanlar G; Ortiz A; Massy Z; Martinez-Castelao A; Agarwal R; Blankestijn PJ; Covic A; London G; Zoccali C; Dekker FW;
    Kidney Int Suppl (2011); 2011 Jun; 1(1):21-23. PubMed ID: 25028623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C is a risk factor for cardiovascular disease.
    Estrada V; Sagastagoitia I
    Rev Clin Esp (Barc); 2019; 219(6):322-323. PubMed ID: 30898317
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Fabrizi F; Verdesca S; Messa P; Martin P
    Dig Dis Sci; 2015 Dec; 60(12):3801-13. PubMed ID: 26195311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C infection is very rarely treated among hemodialysis patients.
    Goodkin DA; Bieber B; Gillespie B; Robinson BM; Jadoul M
    Am J Nephrol; 2013; 38(5):405-12. PubMed ID: 24192505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.
    Roth D; Nelson DR; Bruchfeld A; Liapakis A; Silva M; Monsour H; Martin P; Pol S; Londoño MC; Hassanein T; Zamor PJ; Zuckerman E; Wan S; Jackson B; Nguyen BY; Robertson M; Barr E; Wahl J; Greaves W
    Lancet; 2015 Oct; 386(10003):1537-45. PubMed ID: 26456905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.